Structural Modifications of Thalidomide Produce Analogs with Enhanced Tumor Necrosis Factor Inhibitory Activity
- 1 January 1996
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 39 (17) , 3238-3240
- https://doi.org/10.1021/jm9603328
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- ThalidomideDrug Safety, 1995
- Recognition of thalidomide defects.Journal of Medical Genetics, 1992
- Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.The Journal of Experimental Medicine, 1991
- Asymmetric synthesis of R-β-amino butanoic acid and S-β-tyrosine: Homochiral lithium amide equivalents for Michael additions to α,β-unsaturated esters.Tetrahedron: Asymmetry, 1991
- Thalidomide — A therapy for the immunological consequences of HIV infection?Medical Hypotheses, 1989
- Synthesis of (4R)-D,L-[4-2H]- and (4S)-D,L-[42H]homoserine lactonesThe Journal of Organic Chemistry, 1985
- Thalidomide a promising new treatment for rheumatoid arthritisArthritis & Rheumatism, 1984
- Thalidomide for autoimmune diseaseMedical Hypotheses, 1983
- Study of Absorption, Translocation, and Residue Properties of 2,3,5-Triiodobenzoic Acid in Field-Grown SoybeansJournal of Pharmaceutical Sciences, 1968
- Thalidomide in the treatment of lepra reactionsClinical Pharmacology & Therapeutics, 1965